Epidemiological research on the implication of atherosclerosis in the development of cognitive impairment is lacking in low- and middle-income countries, where two-thirds of the individuals affected by dementia live. Individuals aged ≥65 years living in urban and rural areas of 2 countries in Central Africa were invited. Demographic, clinical, and biological data were collected, and the ankle–brachial index (ABI) was measured. Cognitive impairment was defined according to the Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) criteria. Among 1662 participants (age 72.9 years, 59.3% females), the prevalence of cognitive impairment was 13.6%, which is higher in individuals with ABI ≤ 0.90 and ABI ≥ 1.40 than those with 0.90 < ABI < 1.40 (20.1% and 17% vs 12%, P = .0024). Cognitive impairment was significantly associated with the factors such as age (odds ratio [OR]: 1.09; 95% confidence interval [CI]: 1.07-1.12, P < .0001), female gender (OR: 2.36, 95% CI: 1.59-3.49, P < .0001), smoking (OR: 1.54, 95% CI: 1.06-2.23, P = .0026), and low ABI (≤0.90; OR: 1.52, 95% CI: 1.03-2.25, P = .0359). The ABI, a ubiquitous marker of atherosclerosis, provides independent and incremental information on susceptibility to present with cognitive disorders.
GillTMRichardsonEDTinettiME. Evaluating the risk of dependence in activities of daily living among community-living older adults with mild to moderate cognitive impairment. J Gerontol A Biol Sci Med Sci. 1995;50(5):235–41.
2.
WeilerPGLubbenJEChiI. Cognitive impairment and hospital use. Am J Public Health. 1991;81(9):1153–7.
3.
LiuIYLacroixAZWhiteLRKittnerSJWolfPA. Cognitive impairment and mortality: a study of possible confounders. Am J Epidemiol. 1990;132(1):136–43.
4.
TangMXCrossPAndrewsH. Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology. 2001;56(1):49–56.
5.
PerkinsPAnnegersJFDoodyRSCookeNAdayLVernonSW. Incidence and prevalence of dementia in a multiethnic cohort of municipal retirees. Neurology. 1997;49(1):44–50.
6.
PlassmanBLLangaKMFisherGG. Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology. 2007;29(1-2):125–32.
7.
De la TorreJC. Alzheimer’s disease a neurodegenerative or a vascular disorder? Data, dogma and dialectics. Lancet Neurol. 2004;3(3):184–90.
8.
CriquiMHVargasVDenenbergJO. Ethnicity and peripheral arterial disease: the San Diego Population Study. Circulation. 2005;112(17):2703–7.
9.
FowkesFGRudanDRudanI. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382(9901):1329–40.
10.
SelvinEErlingerTP. Prevalence risk of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999–2000. Circulation. 2004;110(6):738–43.
11.
AboyansVLacroixPLebourdonAPreuxPMFerrièresJLaskarM. The intra and interobserver variability of ankle-arm blood pressure index according to its mode of calculation. J Clin Epidemiol. 2003;56(3):215–20.
12.
AboyansVCriquiMHAbrahamP. Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation. 2012;126(24):2890–909.
13.
GuerchetMAboyansVNubukpoPLacroixPClémentJPPreuxPM. Ankle-brachial index as a marker of cognitive impairment and dementia in general population. A systematic review. Atherosclerosis. 2011;216(2):251–7.
14.
AboyansVHoEDenenbergJOHoLANatarajanLCriquiMH. The association between elevated ankle systolic pressures and peripheral occlusive arterial disease in diabetic and nondiabetic subjects. J Vasc Surg. 2008;48(5):1197–203.
15.
AboyansVLacroixPTranMH. The prognosis of diabetic patients with high ankle-brachial index depends on the coexistence of occlusive peripheral artery disease. J Vasc Surg. 2011;53(4):984–91.
16.
GuerchetMMbelessoPMouangaAM. Association between a low ankle-brachial index and dementia in a general elderly population in Central Africa (Epidemiology of Dementia in Central Africa Study). J Am Geriatr Soc. 2013;61(7):1135–40.
17.
GurejeOOladejiBAbionaT. Incidence and risk factors for late-life depression in the Ibadan Study of Ageing. Psychol Med. 2011;41(9):1897–906.
GuerchetMMbelessoPNdamba-BandzouziB. Epidemiology of dementia in Central Africa (EPIDEMCA): protocol for a multicentre population-based study in rural and urban areas of the Central African Republic and the Republic of Congo. Springerplus. 2014;3:338.
20.
PrinceMFerriCPAcostaD. The protocols for the 10/66 dementia research group population-based research programme. BMC Public Health. 2007;7:165.
21.
ParaïsoMNHouinatoDGuerchetM. Validation of the use of historical events to estimate the age of subjects aged 65 years and over in Cotonou (Benin). Neuroepidemiology. 2010;35(1):12–16.
22.
World Health Organization. Physical Status: The Use and Interpretation of Anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 1995;854:17–452.
23.
AlbertiKGEckelRHGrundySM. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–55.
24.
HallKHendrieHBrittainH. The development of a dementia screening interview in two distinct languages. Int J Meth Psychiatr Res. 1993;3:1–28.
25.
CopelandJRDeweyMEGriffiths-JonesHM. A computerized psychiatric diagnostic system and case nomenclature for elderly subjects: GMS and AGECAT. Psychol Med. 1986;16(1):89–99.
26.
GroberEBuschkeHCrystalHBangSDresnerR. Screening for dementia by memory testing. Neurology. 1988;38(6):900–3.
27.
ZazzoR. Test des deux barrages. Actualités Pédagogiques et Psychologiques. Vol 7. Neuchâtel, Switzerland: Delachaux & Niestlé; 1974.
28.
IsaacsBKennieAT. The Set test as an aid to the detection of dementia in old people. Br J Psychiatry. 1973;123(575):467–70.
29.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, WA: American Psychiatric Association; 1994.
30.
PetersenRC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256(3):183–94.
31.
BretelerMMClausJJGrobbeeDEHofmanA. Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study. BMJ. 1994;308(6944):1604–8.
32.
HofmanAOttABretelerMM. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer’s disease in the Rotterdam Study. Lancet. 1997;349(9046):151–4.
33.
WooJLynnHWongSY. Correlates for a low ankle-brachial index in elderly Chinese. Atherosclerosis. 2008;186(2):360–6.
34.
PriceJFMcDowellSWhitemanMCDearyIJStewartMCFowkesFG. Ankle brachial index as a predictor of cognitive impairment in the general population: ten-year follow-up of the Edinburgh Artery Study. J Am Geriatr Soc. 2006;54(5):763–9.
SugawaraNYasui-FurukoriNUmedaT. Comparison of ankle-brachial pressure index and pulse wave velocity as markers of cognitive function in a community-dwelling population. BMC Psychiatry. 2010;10:46.
37.
OchayiBThacherTD. Risk factors for dementia in central Nigeria. Aging Ment Health. 2006;10(6):616–20.
38.
HallKGurejeOGaoS. Risk factors and Alzheimer’s disease: a comparative study of two communities. Aust N Z J Psychiatry. 1998;32(5):698–706.
39.
OgunniyiABaiyewuOGurejeO. Epidemiology of dementia in Nigeria: results from the Indianapolis-Ibadan study. Eur J Neurol. 2000;7(5):485–90.
40.
GurejeOOgunniyiABaiyewuO. APOE epsilon4 is not associated with Alzheimer’s disease in elderly Nigerians. Ann Neurol. 2006;59(1):182–5.
41.
KalariaRNMaestreGEArizagaR; World Federation of Neurology Dementia Research Group. Alzheimer’s disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol. 2008;7(9):812–26.
42.
JormAF. Is depression a risk factor for dementia or cognitive decline? A review. Gerontology. 2000;46(4):219–27.
43.
GrenonSMHiramotoJSmolderenKGVittinghoffEWhooleyMACohenBE. Association between depression and peripheral artery disease: insights from the heart and soul study. J Am Heart Assoc. 2012;1(4):e002667.
44.
LaurinDMasakiKHWhiteLRLaunerLJ. Ankle-to-brachial index and dementia: the Honolulu-Asia Aging Study. Circulation. 2007;116(20):2269–74.
45.
NewmanABFitzpatrickALLopezO. Dementia and Alzheimer’s disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort. J Am Geriatr Soc. 2005;53(7):1101–7.
46.
JohnsonWPriceJFRafnssonSBDearyIJFowkesFG. Ankle-brachial index predicts level of, but not change in, cognitive function: the Edinburgh Artery Study at the 15-year follow-up. Vasc Med. 2010;15(2):91–97.
47.
van OijenMde JongFJWittemanJCHofmanAKoudstaalPJBretelerMM. Atherosclerosis and risk for dementia. Ann Neurol. 2007;61(5):403–10.
48.
FowkesFGMurrayGDButcherI. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008;300(2):197–208.
49.
GuerchetMAboyansVMbelessoP. Epidemiology of peripheral artery disease in elder general population of two cities of Central Africa: Bangui and Brazzaville. Eur J Vasc Endovasc Surg. 2012;44(2):164–9.
50.
CuiRIsoHYamagishiKTanigawaT. Ankle-arm blood pressure index and cardiovascular risk factors in elderly Japanese men. Hypertens Res. 2003;26(5):377–82.
51.
MeijerWTHoesAWRutgersDBotsMLHofmanAGrobbeeDE. Peripheral arterial disease in the elderly: the Rotterdam study. Arterioscler Thromb Vasc Biol. 1998;18(2):185–92.
